161 related articles for article (PubMed ID: 36200500)
1. [Low-dose lung cancer screening programs - European outlook].
Kerpel-Fronius A
Magy Onkol; 2022 Oct; 66(3):202-206. PubMed ID: 36200500
[TBL] [Abstract][Full Text] [Related]
2. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
5. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.
Han D; Heuvelmans MA; Vliegenthart R; Rook M; Dorrius MD; Oudkerk M
J Thorac Imaging; 2019 Jan; 34(1):65-71. PubMed ID: 30325795
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer screening: a critical appraisal.
Kian W; Zemel M; Levitas D; Alguayn W; Remilah AA; Rahman NA; Peled N
Curr Opin Oncol; 2022 Jan; 34(1):36-43. PubMed ID: 34652284
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.
O'Dowd EL; Baldwin DR
Br J Radiol; 2018 Oct; 91(1090):20170460. PubMed ID: 28749712
[TBL] [Abstract][Full Text] [Related]
8. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
[TBL] [Abstract][Full Text] [Related]
9. CT screening for lung cancer: Are we ready to implement in Europe?
Balata H; Evison M; Sharman A; Crosbie P; Booton R
Lung Cancer; 2019 Aug; 134():25-33. PubMed ID: 31319989
[TBL] [Abstract][Full Text] [Related]
10. The rationale for, and design of, a lung cancer screening program.
Mazzone P
Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
[TBL] [Abstract][Full Text] [Related]
11. The evidence for low-dose CT screening of lung cancer.
Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer screening: the radiologist's perspective.
Prokop M
Semin Respir Crit Care Med; 2014 Feb; 35(1):91-8. PubMed ID: 24481763
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary experiences with low-dose computed tomography for lung cancer screening in Hungary].
Moizs M; Bajzik G; Lelovics Z; Rakvács M; Strausz J; Repa I
Orv Hetil; 2014 Mar; 155(10):383-8. PubMed ID: 24583559
[TBL] [Abstract][Full Text] [Related]
14. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
15. EUPS-argues that lung cancer screening should be implemented in 18 months.
Field JK; Baldwin DR; Devaraj A; Oudkerk M
Br J Radiol; 2018 Oct; 91(1090):20180243. PubMed ID: 29722546
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
Silva M; Pastorino U; Sverzellati N
Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
[TBL] [Abstract][Full Text] [Related]
17. Pearls and Pitfalls in Lung Cancer CT Screening.
Godoy MCB; Lago EAD; Pria HRFD; Shroff GS; Strange CD; Truong MT
Semin Ultrasound CT MR; 2022 Jun; 43(3):246-256. PubMed ID: 35688535
[TBL] [Abstract][Full Text] [Related]
18. [Lung cancer screening: what can we tell our patients while we await a screening program ?].
Selby K; Gubelmann R; Lovis A; Bulliard JL; Beigelman-Aubry C; Casutt A; Peters S; Krueger T; Von Garnier C; Cornuz J
Rev Med Suisse; 2020 Nov; 16(713):2086-2091. PubMed ID: 33146956
[TBL] [Abstract][Full Text] [Related]
19. European and North American lung cancer screening experience and implications for pulmonary nodule management.
Nair A; Hansell DM
Eur Radiol; 2011 Dec; 21(12):2445-54. PubMed ID: 21830100
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
